MeOH extracts of 37 herbs were tested in screening experiments for rat intestinal -glucosidase. The MeOH extract of the aerial parts of Scutellaria lateriflora L. (Lamiaceae) significantly inhibited sucrase and maltase activities, using sucrose and maltase as the substrates. Enzyme inhibition guided-fractionation of the MeOH extract of S. lateriflora resulted in the isolation of a new diterpene glucoside, deacetylajugarin-IV 18-O--D-glucopyranoside (1), along with 20 known phenolics (2-21). The structures of 1-21 were elucidated on the basis of MS and NMR data analyses. Baicalein (4) and baicalin (10), a glycoside of 4, showed moderate sucrase inhibitory activities at IC 50 values of 14.9 and 36.3 M, respectively, whereas luteolin (3), acteoside (16), leucosceptoside A (18), and isoacteoside (20) showed weak inhibitory activities at IC 50 values of 811, 522, 727, and 443 M, respectively. This is the first report on mammalian α-glucosidase inhibitory activities of S. lateriflora extract and identification of the constituents responsible for the activities. Apigenin (2), luteolin (3), 6-methoxyluteolin 4'-methyl ether (6), isoscutellarin 8-O--D-glucuronide (7), luteolin 7-O--D-glucuronide (9), wogonin 7-O--D-glucuronide methyl ester (12), eriodictyol (13), naringenin (14), naringenin 7-O--D-glucuronide (15), jionoside D (17), leucosceptoside A (18), and (+)-syringaresinol 4'-O--Dglucopyranoside (21) were isolated from this plant for the first time. The inhibitory properties of S. lateriflora extract against α-glucosidase provide a prospect for its antidiabetic usage.
Metabolic syndrome, including type 2 diabetes, insulin resistance, obesity/abdominal obesity, hypertension, and dyslipidemia, is a major public health problem. Type 2 diabetes is defined by absolute or relative deficiencies in insulin secretion and/or insulin action associated with chronic hyperglycemia and disturbances of carbohydrate, lipid, and protein metabolism [1] . The chronic hyperglycemia in type 2 diabetes is characterized by both fasting and postprandial hyperglycemia [2] . One of the therapeutic approaches for type 2 diabetes is to decrease the postprandial hyperglycemia by delaying glucose absorption through the inhibition of carbohydrate-hydrolyzing enzymes, such as αglucosidase. From this point of view, over the past few years, many efforts have been made to search for effective inhibitors of αglucosidase from natural materials [3] . These facts prompted us to evaluate the -glucosidase inhibitory activities of herbs used for beverages and to identify the active ingredients.
In the screening experiments for rat intestinal α-glucosidase inhibitors in herbs, 37 materials were tested, using sucrose and maltose as the substrates. The results are shown in Table 1 . Since the MeOH extract of S. lateriflora showed potent sucrase and maltase inhibitory activities, further fractionation of the extract was carried out to isolate the active principles.
The dried aerial parts of S. lateriflora were extracted with MeOH. The MeOH extract, which showedsucrase and maltase inhibitory activities (IC 50 values of 198 and 830 μg/mL, respectively), was passed through a Diaion HP-20 column and successively eluted with MeOH-H 2 O (3:7), MeOH-H 2 O (1:1), MeOH, EtOH, and EtOAc. The MeOH eluate fraction (22 g), which exhibited sucrase inhibitory activity (IC 50 values of 98 μg/mL), was subjected to silica gel column chromatography (CC) and ODS silica gel, as well as preparative HPLC, yielding compounds 1-21. By comparison of the physical and spectroscopic data with literature values, 2-21 were [15] , jionoside D (17) [16] , leucosceptoside A (18) [16] , martynoside (19) [17], isoacteoside (20) [15] , and (+)syringaresinol 4'-O--D-glucopyranoside (21) [18] , respectively. This is the first isolation of 2, 3, 6, 7, 9, 12-15, 17, 18, and 21 from this plant.
Compound 1 was obtained as an amorphous solid, [] D 25 -34.0 in MeOH, with a molecular formula of C 26 H 40 O 10 , which was assigned on the basis of the HRESI-TOFMS (m/z 535.2515 [M + Na] + , calcd 535.2519) and 13 C NMR data (26 carbon signals). The UV spectrum of 1 had absorption maxima at 214 nm. The IR spectrum was consistent with the presence of hydroxy groups (3364 cm −1 ), a carbonyl group of an ,-unsaturated -lactone moiety (1778 cm −1 ), and an ester carbonyl group (1745 cm −1 ). The 1 H NMR spectrum of 1 (C 5 D 5 N) showed signals for two tertiary methyl groups ( 1.36 and 0.69), a secondary methyl group at  0.76 (J = 6.7 Hz), an oxymethylene group at  4.85 (br s, 2H), a hydroxylmethine group at  3.80 (m), an olefinic proton at δ 6.05 (s), and an anomeric proton at  6.32 (d, J = 8.1 Hz). The 13 C NMR spectrum displayed two carbonyl carbon signals at 174.5 and 174.3, a set of olefinic carbon signals at  172.0 and 115.0, as well as two methyl carbon, four methine carbon, two quaternary carbon, and six carbon signals for a hexopyranosyl group. Alkaline methanolysis of 1 with 14% NH 3 in MeOH-H 2 O (1:1) gave 1a and D-glucose. Analysis of the 1 H and 13 C NMR spectroscopic data of 1a allowed the structure to be identified as methyl 6-hydroxy-4-methoxycarbonyl-18norneo-clerod-13(14)-en-15,16-olide (deacetylajugarin-IV) [19] . Identification of D-glucose, including its absolute configuration, was carried out by direct HPLC analysis of the hydrolysate. In the HMBC spectrum of 1, linkage of a -D-glucopyranosyl (Glc) group to C-18 of the aglycone was ascertained by a long-range correlation between the signals at  H 6.32 (d, J=8.1 Hz, H-1 of Glc) and  C 174.5 (C-18 of the aglycone). The structure of 1 was assigned to be deacetylajugarin-IV 18-O--D-glucopyranoside. The isolated compounds 1-21 were evaluated for their sucrase inhibitory activities. 5,6,7-Trihydoroxy flavone (4, baicalein) and its glycoside (10, baicalin) showed moderate sucrase inhibitory activities at IC 50 values of 14.9 and 36.3 M, respectively, whereas 3, 16, 18, and 20 showed weak inhibitory activities at IC 50 values of 811, 522, 727, and 443 M, respectively. The other compounds did not show inhibitory activities at 1000 M.
To the best of our knowledge, this is the first report on mammalian α-glucosidase inhibitory activities of S. lateriflora extract and identification of the constituents responsible for the activities. Compounds 2, 3, 6, 7, 9, 12, 13, 14, 15, 17, 18, and 21 were isolated from this plant for the first time. The inhibitory properties of S. lateriflora extract against α-glucosidase provide a prospect for its antidiabetic usage.
Experimental
General: Optical rotations were measured using a JASCO P-1030 (Tokyo, Japan) automatic digital polarimeter. IR and UV spectra were recorded on a JASCO FT-IR 620 and a JASCO V-630 J (Hz) 13 C J (Hz) Chemical constituents of Scutellaria lateriflora Natural Product Communications Vol. 7 (4) 2012 473 spectrophotometer, respectively. NMR spectra were recorded on a Bruker DRX-500 spectrometer (500 MHz for 1 H NMR, Karlsruhe, Germany) using standard Bruker pulse programs. Chemical shifts are given as -value with reference to tetramethylsilane (TMS) as an internal standard. HRESI-TOFMS data were obtained on a Waters-Micromass LCT mass spectrometer (Manchester, U.K.). Diaion HP-20 (Mitsubishi-Chemical, Tokyo, Japan), silica gel (Fuji-Silysia Chemical, Aichi, Japan), and ODS silica gel (Nacalai Tesque, Kyoto, Japan) were used for CC. TLC was carried out on precoated Silica gel 60 F 254 (0.25 mm or 0.5 mm thick, Merck, Darmstadt, Germany) and RP-18 F 254S (0.25 mm thick, Merck) plates, and spots were visualized by spraying with 10% H 2 SO 4 followed by heating. HPLC was performed by using a system comprised of a CCPM pump (Tosoh, Tokyo, Japan), a CCP PX-8010 controller (Tosoh), an RI-8010 detector (Tosoh), and a Rheodyne injection port. A TSKgel ODS-100Z column (10 mm i.d.
x 250 mm, 5 m, Tosoh) was used for preparative HPLC. All other chemicals used were of biochemical reagent grade.
Plant material:
The 37 herbal materials used in the experiments were obtained from Connect Co. Ltd. (Tokyo, Japan). The voucher specimens are preserved in our laboratory.
Intestinal -glucosidase inhibitory activity determination:
The α-glucosidase inhibitory activities of the plant extracts and isolated compounds were measured as follows. Rat intestine acetone powder (3 g, Sigma-Aldrich Japan, Tokyo, Japan) in 56 μM maleate buffer (pH 6.0, 9 mL) was homogenated in an ice bath for 30 min, then centrifuged at 3,000g at 4°C for 10 min. The supernatant was then diluted by adding a two fold volume of 56 μM maleate buffer which was used as sucrase solution, and by adding a twenty fold volume of 56 μM maleate buffer which was used as maltase solution. The sucrose or maltose in the 56 μM maleate buffer (20 mg/mL) was used as a substrate solution. The enzyme solution (150 L) was mixed with 50 L of the test samples in dimethyl sulfoxide. After preincubation at 37°C for 5 min, the substrate solution (200 L) was added to the mixture. The mixture was incubated for 20 min at 37°C, and heated in boiling water for 5 min to stop the reaction. The glucose release was determined using a glucose assay kit (Glucose CII-test Wako, Wako Pure Chemicals, Osaka, Japan) based on the glucose oxidase/peroxidase method. Acarbose was used as the positive control with an IC 50 value of 1.32 M to sucrase and 0.29 M to maltase in this assay system.
Extraction and isolation:
The aerial parts of S. lateriflora (500 g of dry weight) were extracted with hot MeOH (12 L). After removing the solvent, the MeOH extract (85 g), which showedsucrase and maltase inhibitory activities (IC 50 198 and 830 μg/mL, respectively), was passed through a Diaion HP-20 column and successively eluted with MeOH-H 2 O (3:7), MeOH-H 2 O (1:1), MeOH, EtOH, and EtOAc. The MeOH eluate fraction exhibited sucrase inhibitory activity (IC 50 98 μg/mL). CC of the MeOH eluate portion (22 g) on silica gel and elution with a stepwise gradient mixture of CHCl 3 -MeOH-H 2 O (9:1:0; 40:10:1; 20:10:1), and finally with MeOH alone, gave eight fractions (I-VIII). Fraction III was subjected to silica gel CC eluted with hexane-Me 2 CO (2:1) to collect 11 subfractions (III-1-11). Fraction III-7 was applied to ODS silica gel CC eluted with MeOH-H 2 O (11:9) to afford 11 subfractions (III-7-a-k). Fraction III-7-c was subjected to CC on ODS silica gel eluted with MeOH-H 2 O (2:3) to give 5 (240 mg) and 14 (35.8 mg). Fraction III-7-f was applied to silica gel CC eluted with CHCl 3 -H 2 O (49:1) to afford 2 (32.7 mg) and 4 with few impurities. Compound 4 (8.1 mg) was purified by preparative HPLC using MeCN-H 2 O (2:3). Fraction III-9 was applied to ODS silica gel CC eluted with MeOH-H 2 O (17:3) to afford 6 (37.4 mg). Fraction V was chromatographed on silica gel eluted with CHCl 3 -MeOH (49:1; 9:1) to collect 11 subfractions (V-1-11). Fraction V-4 was applied to ODS silica gel CC eluted with MeOH-H 2 O (3:2 UV  max nm (log ): 214 (4.09). 1 H NMR (500 MHz, C 5 D 5 N): Table 1 . 13 C NMR (125 MHz, C 5 D 5 N): Table 1 . HRESI-TOFMS : m/z [M + Na] + , calcd for C 26 H 40 O 10 Na (calcd. 535.2519); found: 535.2515.
Alkaline methanolysis of 1:
Compound 1 (10.0 mg) was treated with 14% NH 3 in MeOH-H 2 O (1:1, 4 mL) at room temperature for 30 min. The reaction mixture was neutralized by passing through an Amberlite IR120 (Organo, Tokyo, Japan) column and chromatographed on ODS silica gel eluted with MeCN-H 2 O (1:1) to yield 1a (4.7 mg) and a sugar fraction (4.5 mg). The sugar fraction was dissolved in H 2 O (2 mL) and passed through a Sep-Pak C18 cartridge (Waters, Milford, MA, U.S.A.), which was then analyzed by HPLC under the following conditions: column, Capcell Pak NH 2 UG80 (4.6 mm i.d. × 250 mm, 5 μm, Shiseido, Tokyo, Japan); solvent, MeCN-H 2 O (17:3); detection, RI and OR; flow rate, 1.0 mL/min. Identification of D-glucose was carried out by comparison of its retention time and optical rotation with those of authentic samples; t R (min) 18.0 (D-glucose, positive polarity).
